C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2011
03/15/2011	US7906309 Prepartion of chrysosporium glycosyl hydrolase in fungal expression system
03/15/2011	US7906308 Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
03/15/2011	US7906307 Transforming the Bacillus cell with a heterologous nucleotide sequence encoding a lipid acyltransferase, expressing the lipid acyltransferase in the cell, transforming the Bacillus licheniformis cell with a heterologous nucleotide sequence, expressing the lipid acyltransferase
03/15/2011	US7906300 Sodium/potassium ATPase regulation
03/15/2011	US7906299 Assay for low molecular weight heparin
03/15/2011	US7906298 Thermostable Photinus pyralis luciferase mutant
03/15/2011	US7906295 Method and apparatus for viable and nonviable prokaryotic and eukaryotic cell quantitation
03/15/2011	US7906294 Prognosis and treatment of breast cancer
03/15/2011	US7906292 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use
03/15/2011	US7906289 Using genetic polymorphisms of the BICD1 gene as a method for diagnosing and treating myopia
03/15/2011	US7906288 Compare-MS: method rapid, sensitive and accurate detection of DNA methylation
03/15/2011	US7906287 Methods of screening nucleic acids for single nucleotide variations
03/15/2011	US7906286 Probe set, probe carrier, and method for determining and identifying fungus
03/15/2011	US7906285 Random array DNA analysis by hybridization
03/15/2011	US7906284 Arrays of optical confinements and uses thereof
03/15/2011	US7906283 Using polymorphism in glutamate receptor as prognostic tool in prediciting risk of treatment-emergent suicidal ideation
03/15/2011	US7906281 Method to predict the response to lithium treatment
03/15/2011	US7906280 Methods of producing intrachain fluorophore-quencher FRET-aptamers and assays
03/15/2011	US7906279 Methods for nucleic acid manipulation
03/15/2011	US7906278 Diagnosis of osteoarthritis by determination of asporin RNA levels
03/15/2011	US7906277 Compound and methods for diagnosis of tuberculosis
03/15/2011	US7906276 Enzymatic detection techniques
03/15/2011	US7906009 Small volume in vitro analyte sensor
03/15/2011	US7905998 Biosensor
03/15/2011	US7905848 Hybrid immobilisation device
03/15/2011	CA2714824A1 Methods and compositions for improved fertilization and embryonic survival
03/15/2011	CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases
03/15/2011	CA2494063C Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit
03/15/2011	CA2482192C Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
03/15/2011	CA2429526C Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
03/15/2011	CA2429134C A method for generating genetically altered antigens
03/15/2011	CA2412992C Integrated microarray devices
03/15/2011	CA2380833C Proteins derived from white spot syndrome virus and uses thereof
03/15/2011	CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
03/15/2011	CA2337949C Methods of populating data structures for use in evolutionary simulations
03/15/2011	CA2192262C Method for purification and transfer to separation/detection systems of dna sequencing samples and plates used therefor
03/11/2011	CA2772929A1 Methods for treating, diagnosing, and monitoring rheumatoid arthritis
03/11/2011	CA2709621A1 Markers and methods relating to the assessment of alzheimer's disease
03/10/2011	WO2011029034A2 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
03/10/2011	WO2011029007A2 Human lymphoid tissue inducer (lti) cell compositions and methods of use
03/10/2011	WO2011028980A2 Markers for detecting cancer cells
03/10/2011	WO2011028974A1 Methods and kits for determining viral load in clinical samples
03/10/2011	WO2011028945A1 Methods for treating, diagnosing, and monitoring rheumatoid arthritis
03/10/2011	WO2011028933A1 Type 1 interferon diagnostic
03/10/2011	WO2011028905A1 Method for categorizing circulating tumor cells
03/10/2011	WO2011028897A1 Methods for identifying a virulent strain of virus
03/10/2011	WO2011028887A2 Methods and compositions for direct chemical lysis
03/10/2011	WO2011028836A2 Herbicide-tolerant plants
03/10/2011	WO2011028826A2 Reversible current gel electrophoresis device for separating biological macromolecules
03/10/2011	WO2011028819A1 Synergistic transcription modules and uses thereof
03/10/2011	WO2011028818A2 High throughput multichannel reader and uses thereof
03/10/2011	WO2011028698A2 Mri and optical assays for proteases
03/10/2011	WO2011028697A2 Uses of cd 116 expression level
03/10/2011	WO2011028539A1 System for mixing fluids by coalescence of multiple emulsions
03/10/2011	WO2011028533A2 Methods for detecting dna methylation using encoded particles
03/10/2011	WO2011028507A2 Compositions, methods, and kits for determining an alkyl transferase
03/10/2011	WO2011028494A2 Label-free sensing of pna-dna complexes using nanopores
03/10/2011	WO2011028488A1 Ubiquitin proteasome system profiling and the use thereof in clinical applications for proliferative hematological disorders
03/10/2011	WO2011028483A2 Methods and apparatus for segregation of particles, including additional sources of sample collection for separation of nucleated fetal cells
03/10/2011	WO2011028296A2 Sequence determination by use of opposing forces
03/10/2011	WO2011028134A1 Biological markers and uses therefor
03/10/2011	WO2011028120A1 Method for increasing the level of zeaxanthin in a plant line, method for selecting a plant or part thereof, including a seed and tuber, and use thereof
03/10/2011	WO2011028041A2 Td probe and its uses
03/10/2011	WO2011027990A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof
03/10/2011	WO2011027966A2 Td probe and its uses
03/10/2011	WO2011027893A1 Method for prediction of therapeutic effect on chronic hepatitis c
03/10/2011	WO2011027875A1 Agent for improving intestinal tract barrier function
03/10/2011	WO2011027810A1 Method for detection of allergen-specific lymphocytes
03/10/2011	WO2011027800A1 Use of biomarker(s) to identify a wee1 inhibitor responsive patient and methods of treating cancer mediated by dysfunctional or aberrant p53 via administration of a wee1 inhibitor
03/10/2011	WO2011027722A1 Composition for reverse transcription polymerase chain reaction
03/10/2011	WO2011027718A1 Method and kit for measuring enzymatic activities of various cytochrome p450 molecule species comprehensively and with high efficiency
03/10/2011	WO2011027554A1 Method for transporting potassium ion from front side to back side of lipid bilayer membrane
03/10/2011	WO2011027552A1 Method for transporting potassium ion from front side to back side of lipid bilayer membrane
03/10/2011	WO2011027332A2 Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereof
03/10/2011	WO2011027292A1 Array-based method for detection of copy number variations in the hla locus for the genetic determination of susceptibility of development of venous malformations in the extracranial segments of the cerebrospinal veins and kit thereof
03/10/2011	WO2011027268A2 Devices and methods for microarray selection
03/10/2011	WO2011027221A1 Method of assessing islet function
03/10/2011	WO2011027219A1 High throughput detection of small genomic deletions and insertions
03/10/2011	WO2011027218A1 High throughput detection of genomic copy number variations
03/10/2011	WO2011027075A1 Identifying viral cell tropism
03/10/2011	WO2011026909A1 Epidermal differentiation microrna signature and uses thereof
03/10/2011	WO2011026815A1 Compositions and methods for treating growth hormone deficiency
03/10/2011	WO2011026429A1 Methods and compositions for detection of lethal cell and uses thereof
03/10/2011	WO2011026222A1 Transformed human pluripotent stem cells and associated methods
03/10/2011	WO2011026221A1 Methods of culturing embryoid bodies
03/10/2011	WO2011026194A1 Nucleic acid extraction
03/10/2011	WO2011026185A1 An assay for monitoring a neurological condition
03/10/2011	WO2011026182A1 Improved nucleic acid quantitation method
03/10/2011	WO2011012848A8 Improvements relating to sensor devices
03/10/2011	WO2011008942A3 Simultaneous quantitative multiple primer detection of clostridium difficile
03/10/2011	WO2011005779A9 Biomarkers for the early detection of autoimmune diseases
03/10/2011	WO2011005220A8 Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
03/10/2011	WO2010151771A3 Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetella
03/10/2011	WO2010150922A3 Methods for screening for anti-graying agents on the basis of aff-4 expression
03/10/2011	WO2010149332A9 Polynucleotides for use in medicine
03/10/2011	WO2010145796A3 Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy
03/10/2011	WO2010139812A4 miRNA FINGERPRINT IN THE DIAGNOSIS OF DISEASES
03/10/2011	WO2010138963A3 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents
03/10/2011	WO2010135692A3 Mirna biomarkers of prostate disease
03/10/2011	WO2010134499A3 Primer set for detecting listeria bacteria

1 ... 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 ... 3003